The company

The pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications.


Bart. van den Berg (MSc) CEO
Joined the company in June 2004, Mr. van den Berg is former general manager and co-founder of two pharmaceutical contract manufacturing companies and founder of VenGen BV, a life sciences start-up management company. He was trained in business economics at Tilburg University, the Netherlands.
Michiel Kregel, PhD Operations Manager
Before joining DiagnOptics in 2013, Mr. Kregel has worked as a product manager and as a consultant in photonics and in spatial information technology. He has managed technical project teams in various settings, such as fluorescence microscopy and geodesy. He has a PhD in Astrophysics from Groningen      University, The Netherlands.
Jasper Dijkstra (MSc) Commercial Manager
Has a Master’s degree Medical Biology from the University of Groningen (the Netherlands). During his master program he specialized in policy and business issues that are involved in innovation in Life Sciences. Prior to joining DiagnOptics in 2009, Mr. Dijkstra worked as a Technology Transfer Officer at the University of Groningen.
More Information
Request informations

Would you like to learn more about our products? Request any information you wish to receive here.


Our contact details


Follow us on LinkedIn

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a